Collegium Pharmaceutical, Inc. (COLL) Social Stream
COLLEGIUM PHARMACEUTICAL INC (COLL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering COLLEGIUM PHARMACEUTICAL INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $36 | $8 | $24.857 | $22.55 | 10.23% |
| 2021-11-28 | 8 | $36 | $8 | $25.142 | $22.55 | 11.49% |
| 2022-01-11 | 6 | $36 | $8 | $25.142 | $22.55 | 11.49% |
| 2022-01-21 | 6 | $36 | $8 | $25 | $22.55 | 10.86% |
| 2022-02-15 | 7 | $36 | $8 | $25.5 | $22.55 | 13.08% |
| 2022-02-25 | 7 | $42 | $8 | $26.5 | $22.55 | 17.52% |
| 2022-04-06 | 7 | $42 | $8 | $27 | $22.55 | 19.73% |
| 2022-04-28 | 7 | $40 | $8 | $26.666 | $22.55 | 18.25% |
| 2022-05-10 | 7 | $37 | $8 | $26.166 | $22.55 | 16.04% |
| 2022-07-18 | 8 | $37 | $8 | $27.714 | $22.55 | 22.9% |
| 2022-08-05 | 5 | $37 | $8 | $25.4 | $22.55 | 12.64% |
| 2022-11-30 | 6 | $35 | $8 | $25.8 | $22.55 | 14.41% |
| 2023-01-06 | 6 | $40 | $8 | $30.2 | $22.55 | 33.92% |
| 2023-01-09 | 6 | $35 | $8 | $27.4 | $22.55 | 21.51% |
| 2023-02-08 | 6 | $35 | $26 | $32.25 | $22.55 | 43.02% |
| 2023-02-12 | 6 | $36 | $26 | $32.5 | $22.55 | 44.12% |
| 2023-02-16 | 6 | $40 | $33 | $36 | $22.55 | 59.65% |
| 2023-04-19 | 6 | $40 | $33 | $36.25 | $22.55 | 60.75% |
| 2023-04-25 | 6 | $40 | $33 | $35.75 | $22.55 | 58.54% |
| 2023-05-09 | 6 | $40 | $30 | $35 | $22.55 | 55.21% |
| 2023-07-04 | 7 | $40 | $30 | $34.6 | $22.55 | 53.44% |
| 2023-07-25 | 6 | $35 | $30 | $33.25 | $22.55 | 47.45% |
| 2023-08-08 | 6 | $37 | $30 | $33.75 | $22.55 | 49.67% |
| 2023-08-25 | 6 | $37 | $30 | $34 | $22.55 | 50.78% |
The Trend in the Analyst Price Target
COLL's average price target has moved up $4.43 over the prior 29 months.
Over the past 42 weeks, COLL's average upside potential has been 39.8%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-04 | 6 | 35 | 8 | 25.80 | 18.84 | 36.94% |
| 2023-01-05 | 6 | 35 | 8 | 27.40 | 28.04 | -2.28% |
| 2023-02-16 | 6 | 40 | 33 | 36.00 | 26.55 | 35.59% |
| 2023-04-19 | 6 | 40 | 33 | 36.25 | 22.88 | 58.44% |
| 2023-05-09 | 7 | 40 | 30 | 35.00 | 23.53 | 48.75% |
COLL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 4 | 1 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
COLL's average broker recommendation rating improved by 0.12 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for COLL as an investment opportunity.
- COLLEGIUM PHARMACEUTICAL INC's variance in analysts' estimates is lower than -1756.75% of all US stocks.
- In terms of how COLLEGIUM PHARMACEUTICAL INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 628.56% of that group.
- COLL has a greater number of analysts covering the stock than 2262.77% of stocks in the small market cap category.
- COLLEGIUM PHARMACEUTICAL INC's average analyst price target is higher than 2090.18% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to COLLEGIUM PHARMACEUTICAL INC are RDHL, KMDA, and IMMP.
View All Top Stocks by Price Target
What is the outlook for COLL? Use POWR Ratings for clearer insight into price direction.